Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus

Nature

Volumn 437, Issue 7061, 2005, Pages 975-980

  Mygind, Per H ^a   Fischer, Rikke L ^b   Schnorr, Kirk M ^a   Hansen, Mogens T ^a   Sönksen, Carsten P ^a   Ludvigsen, Svend ^c   Raventós, Dorotea ^a   Buskov, Steen ^a   Christensen, Bjarke ^a   De Maria, Leonardo ^a   Taboureau, Olivier ^a,c   Yaver, Debbie ^d   Elvig Jørgensen, Signe G ^a   Sørensen, Marianne V ^a   Christensen, Bjørn E ^a   Kjærulff, Søren ^a   Frimodt Moller, Niels ^b   Lehrer, Robert I ^e   Zasloff, Michael ^f   Kristensen, Hans Henrik ^a  

^a NOVOZYMES A S   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c NOVO NORDISK A S   (Denmark)

^d Novozymes Biotech Inc   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; BACTERIA; FUNGI; GENES; PLANTS (BOTANY); TOXICITY; VIRUSES;

DEFENSIN; MUSSELS; PEPTIDE ANTIBIOTICS; PLECTASIN;

PROTEINS;

DEFENSIN; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; RECOMBINANT PLECTASIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VANCOMYCIN;

MEDICINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCOMYCETES; CONTROLLED STUDY; DRUG ACTIVITY; DRUG HALF LIFE; FUNGUS; MOUSE; MUSSEL; NONHUMAN; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN STRUCTURE; SCORPION; SPIDER; STREPTOCOCCUS PNEUMONIAE;

ANIMALIA; ANISOPTERA (DRAGONFLIES); ARANEAE; EMBRYOPHYTA; FUNGI; HEXAPODA; MOLLUSCA; PSEUDOPLECTANIA NIGRELLA; SCORPIONES; STREPTOCOCCUS PNEUMONIAE;

EID: 27144504220     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature04051     Document Type: Article

References (46)

1. Tossi, A., Sandri, L. & Giangaspero, A. Amphipathic, α-helical antimicrobial peptides. Biopolymers 55, 4-30 (2000).
2. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 415, 389-395 (2002).
3. Boman, H. G. Innate immunity and the normal microflora. Immunol. Rev. 173, 5-16 (2000).
4. Matsuzaki, K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta Biomembr. 1462, 1-10 (1999).
5. Yang, L., Weiss, T. M., Lehrer, R. I. & Huang, H. W. Crystallization of antimicrobial pores in membranes: magainin and protegrin. Biophys. J. 79, 2002-2009 (2000).
6. Shai, Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta Biomembr. 1462, 55-70 (1999).
7. Park, C. B., Kim, H. S. & Kim, S. C. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 244, 253-257 (1998).
8. Kragol, G. et al. The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. Biochemistry 40, 3016-3026 (2001).
9. Del Castillo, F. J., Del Castillo, I. & Moreno, F. Construction and characterization of mutations at codon 751 of the Escherichia coli gyrB gene that confer resistance to the antimicrobial peptide microcin B17 and alter the activity of DNA gyrase. J. Bacteriol. 183, 2137-2140 (2001).
10. Gennaro, R., Zanetti, M., Benincasa, M., Podda, E. & Miani, M. Pro-rich antimicrobial peptides from animals: structure, biological functions and mechanism of action. Curr. Pharm. Des. 8, 763-778 (2002).
11. Lehrer, R. I. & Ganz, T. Cathelicidins: a family of endogenous antimicrobial peptides. Curr. Opin. Hematol. 9, 18-22 (2002).
12. Zanetti, M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75, 39-48 (2004).
13. Lehrer, R. I. Primate defensins. Nature Rev. Microbiol. 2, 727-738 (2004).
14. Ganz, T. Defensins: antimicrobial peptides of innate immunity. Nature Rev. Immunol. 3, 710-720 (2003).
15. Selsted, M. E., Szklarek, D. & Lehrer, R. I. Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes. Infect Immun. 45, 150-154 (1984).
16. Selsted, M. E., Szklarek, D., Ganz, T. & Lehrer, R. I. Activity of rabbit leukocyte peptides against Candida albicans. Infect. Immun. 49, 202-206 (1985).
17. Lehrer, R. I., Daher, K., Ganz, T. & Selsted, M. E. Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leukocytes. J. Virol. 54, 467-472 (1985).
18. Daher, K., Selsted, M. E. & Lehrer, R. I. Direct inactivation of viruses by human granulocyte defensins. J. Virol. 60, 1068-1074 (1986).
19. Cole, A. M. Minidefensins and other antimicrobial peptides: candidate anti-HIV microbicides. Expert Opin. Ther. Targets 7, 329-341 (2003).
20. Yang, D. et al. β-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286, 525-528 (1999).
21. Biragyn, A. et al. Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 298, 1025-1029 (2002).
22. Becker, F. et al. Development of in vitro transposon assisted signal sequence trapping and its use in screening Bacillus halodurans C125 and Sulfolobus solfataricus P2 gene libraries. J. Microbiol. Methods 57, 123-133 (2004).
23. Schnorr, K., Hansen, M. T., Mygind, P. H., Segura, D. R. & Kristensen, H.-H. Novel plectasin polypeptide having antimicrobial activity, useful for (for example) killing or inhibiting microbial cell growth, for use as a medicament and as antimicrobial therapeutic or prophylactic agent. International patent application WO2003044049-A1 (2003).
24. Froy, O. & Gurevitz, M. Arthropod defensins illuminate the divergence of scorpion neurotoxins. J. Pept. Sci. 10, 714-718 (2004).
25. Yang, Y. S. et al. Solution structure and activity of the synthetic four-disulfide bond Mediterranean mussel defensin (MGD-1). Biochemistry 39, 14436-14447 (2000).
26. Landon, C., Sodano, P., Hetru, C., Hoffmann, J. & Ptak, M. Solution structure of drosomycin, the first inducible antifungal protein from insects. Protein Sci. 6, 1878-1884 (1997).
27. Volkoff, A. N. et al. Characterization and transcriptional profiles of three Spodoptera frugiperda genes encoding cysteine-rich peptides. A new class of defensin-like genes from lepidopteran insects? Gene 319, 43-53 (2003).
28. Bulet, P. et al. A novel insect defensin mediates the inducible antibacterial activity in larvae of the dragonfly Aeschna cyanea (Paleoptera, Odonata). Eur. J. Biochem. 209, 977-984 (1992).
29. Doolittle, R. F., Feng, D. F., Tsang, S., Cho, G. & Little, E. Determining divergence times of the major kingdoms of living organisms with a protein clock. Science 271, 470-477 (1996).
30. The Clinical and Laboratory Standards Institute (formerly the National Commmittee for Clinical Laboratory Standards). Guideline M7-A6: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. (http://www.nccls.org).
31. Steinberg, D. A. & Lehrer, R. I. in Methods in Molecular Biology Vol. 78 (ed. Schafer, W. M.) 169-186 (Humana, Totowa, New Jersey, 1997).
32. Frimodt-Møller, N., Knudsen, J. D. & Espersen, F. in Handbook of Animal Models of Infection (eds Zak, O. & Sande, M. A.) 127-136 (Academic, London, 1999).
33. Erlendsdottir, H. et al. Penicillin pharmacodynamics in four experimental pneumococcal infection models. Antimicrob. Agents Chemother. 45, 1078-1085 (2001).
34. Bayles, K. W. The bactericidal action of penicillin: New clues to an unsolved mystery. Trends Microbiol. 8, 274-278 (2000).
35. Williams, D. H. & Bardsley, B. The vancomycin group of antibiotics and the fight against resistant bacteria. Angew. Chem. Int. Edn Engl. 38, 1173-1193 (1999).
36. Nakajima, Y. et al. Antibacterial activity and mechanism of action of tick defensin against Gram-positive bacteria. Biochim. Biophys. Acta 1624, 125-130 (2003).
37. Hjort, C. M. in Genetically Engineered Food: Methods and Detection (ed. Heller, K. J.) 86-99 (Wiley, 2003).
38. Yoder, W. T. & Lehmbeck, J. in Advances in Fungal Biotechnology for Industry, Agriculture, and Medicine (eds Tkacz, J. S. & Lange, L.) 201-219 (Kluwer Academic/Plenum, New York, 2004).
39. The Advisory Committee on Immunization Practices. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly Rep. 46, 1-24 (1997).
40. Klugman, K. P. Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections. Eur. Respir. J. 20 (suppl.), 3s-8s (2002).
41. Fleming, A. On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenza. Br. J. Exp. Pathol. 10, 226-236 (1929).
42. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J. & Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299 (1979).
43. Ludvigsen, S., Thim, L., Blom, A. M. & Wulff, B. S. Solution structure of the satiety factor, CART, reveals new functionality of a well-known fold. Biochemistry 40, 9082-9088 (2001).
44. Kjær, M., Andersen, K. V. & Poulsen, F. M. Automated and semiautomated analysis of homo- and heteronuclear multidimensional nuclear magnetic resonance spectra of proteins: the program PRONTO. Methods Enzymol. 239, 288-307 (1994).
45. Laskowski, R. A., Rullmann, J. A., Macarthur, M. W., Kaptein, R. & Thornton, J. M. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8, 477-486 (1996).
46. DeLano, W. L. The PyMOL Molecular Graphics System (http://www.pymol.org) (DeLano Scientific, San Carlos, California, 2002).